Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.67ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.277ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.28 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.272ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.371ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.353ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.407ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AA.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.182ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.218ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.12.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.22 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used